Sharing is Caring

Queen Elizabeth, 94, and her husband Prince Philip  is set to receive the Covid-19 Vaccine in the coming weeks. They are being given a priority because of their advanced age.

Britain has pre-ordered 40 million doses of the Covid-19 vaccine and 800,000 doses will be received as an initial batch for roll-out next week.

The vaccine we are talking about were produced by Pfizer-BioNTechn and United Kingdom regulators have given the company a green-light or emergency approval.

The senior-most royals will be among the first to receive the vaccine in order to encourage citizens to be vaccinated.

The oldest and most vulnerable British citizens will be given priority in accessing the said vaccine. The homes for the elderly and their carers will be inoculated followed by those above 80 years as well as front-line workers and care staff.

According to British newspapers, several high profile individuals have promised to take the vaccine in front of cameras to encourage many people in the country to accept to be vaccinated.

According to the regulars in UK, the vaccine produced by Pfizer-BioNTech, it meets all the safety standards. UK becomes the first country in the world to approve a vaccine for Covid-19.

The vaccines will be manufactured at factories owned by Pfizer in Puurs, Belgium. It will then be transported thermal shippers that use dry ice to control the temperatures.

Military aircrafts will also be deployed to fly in millions of Covid-19 doses from Belgium to Britain especially if Brexit related disruptions affect the UK ports. These are just contingency plans.

Four days ago trucks carrying the vaccine left Belgium for the United Kingdom. Our fingers are closed, let us hope that this works and more importantly people in developing countries like Kenya get access to the vaccines.

Speaking to the Press at No. 10, he said, “the biggest programme of mass vaccination in the history of the UK is about to begin.”

GOT a story? RING Kerosi Dotcom on +254 20 78 64 348 or EMAIL



Verified by MonsterInsights